Market Analysis - Bioinformatics Congress 2017
Global Life Science Market Analysis:
The global life sciences business process outsourcing market is estimated to reach USD 210 Billion in 2020, growing at a CAGR of 9.2% from 2016 to 2020, due to drug patent expirations worldwide. Active Pharmaceutical Ingredients manufacturing, research and development, clinical data management, pharmacovigilance, medical writing, and regulatory services are the key elements driving the business process outsourcing market. Asia Pacific region has been the most attractive destination for life sciences business process outsourcing.
Europe Life Science Market Analysis:
Global Market Analysis of Bioinformatics:
The bioinformatics market is projected to reach USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing at a CAGR of 21.1% during the forecast period. Global bioinformatics market size was valued at USD 3.51 billion in 2013. Growing demand in the process of novel drug research and development and private and public funding initiatives to support R&D exercises are expected to be a high impact rendering drivers during the forecast period. Furthermore, introduction of user friendly and readily bioinformatics software such as RASMOL, AUTODOCK, BALL, Bioclipse and growing market usage of these tools for accurate and effective analysis of biomarkers discovery programs that assist in toxicity detection during the initial stage of the drug development process are expected to drive the industry growth over the next five years.
The 9th International Conference on Bioinformatics is going to be held during October 23-24, 2017 in France’s most populous city Paris. The conference focuses on foremost topics such as Evolutionary Bioinformatics, Proteomics, Systems Biology, Genomics, Immunology and Drug Discovery, Algorithms & Databases, Clinical Informatics, Biostatistics, Structural Bioinformatics and Clinical Case Reports.